We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.04%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
+$617M
(+40%)
Cap. Flow
+$399M
Cap. Flow
% of AUM
18.35%
Top 10 Holdings %
Top 10 Hldgs %
22.83%
Holding
3,224
New
565
Increased
1,310
Reduced
679
Closed
193
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$52.4M |
| 2 |
Panagram BBB-B CLO ETF
CLOZ
|
+$37.6M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$29.3M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
+$24.4M |
| 5 |
Merck
MRK
|
+$21.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$21.9M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$20.7M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$19.4M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$19.2M |
| 5 |
Invesco Ultra Short Duration ETF
GSY
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.5% |
| 2 | Financials | 4.24% |
| 3 | Healthcare | 3.21% |
| 4 | Consumer Discretionary | 2.76% |
| 5 | Industrials | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Cirrus Logic
CRUS
$6.23B
| $90.4K | ﹤0.01% |
867
+313
| +56% | +$30.7K |
|
977
Akebia Therapeutics
AKBA
$256M
| $90.3K | ﹤0.01% |
24,817
| – | – |
|
978
HEICO Corp
HEI
$50.8B
| $90.2K | ﹤0.01% |
270
+161
| +148% | +$44.5K |
|
979
Quest Diagnostics
DGX
$26.3B
| $90K | ﹤0.01% |
501
+61
| +14% | +$10.6K |
|
980
iShares Global Tech ETF
IXN
$8.74B
| $89.5K | ﹤0.01% |
914
-449
| -33% | -$36.4K |
|
981
Simplify Enhanced Income ETF
HIGH
$70.4M
| $89.4K | ﹤0.01% |
3,688
-9,033
| -71% | -$214K |
|
982
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.3B
| $89.2K | ﹤0.01% |
3,038
+1,409
| +86% | +$38.8K |
|
983
Prudential Financial
PRU
$41.9B
| $89K | ﹤0.01% |
615
+147
| +31% | +$15.2K |
|
984
Willis Towers Watson
WTW
$31.6B
| $88.6K | ﹤0.01% |
289
+159
| +122% | +$49.3K |
|
985
Takeda Pharmaceutical
TAK
$54.4B
| $88.4K | ﹤0.01% |
773
+539
| +230% | +$7.96K |
|
986
Innovator US Equity Accelerated Plus ETF July
XTJL
$13.7M
| $88.4K | ﹤0.01% |
2,460
| – | – |
|
987
Cabot Corp
CBT
$4.52B
| $88.2K | ﹤0.01% |
1,176
+714
| +155% | +$54.6K |
|
988
Edwards Lifesciences
EW
$51.5B
| $88.2K | ﹤0.01% |
1,103
-16
| -1% | -$1.19K |
|
989
Huntington Ingalls Industries
HII
$12.7B
| $87.9K | ﹤0.01% |
242
+116
| +92% | +$25.9K |
|
990
Markel Group
MKL
$23.2B
| $87.9K | ﹤0.01% |
39
| – | – |
|
991
DexCom
DXCM
$31.3B
| $87.6K | ﹤0.01% |
971
+506
| +109% | +$39.7K |
|
992
GoDaddy
GDDY
$11.4B
| $87.5K | ﹤0.01% |
486
+473
| +3,638% | +$84.9K |
|
993
First Trust Indxx Metaverse ETF
ARVR
$5.6M
| $87.4K | ﹤0.01% |
1,853
| – | – |
|
994
Columbia Research Enhanced Core ETF
RECS
$6.03B
| $87.4K | ﹤0.01% |
2,376
-737
| -24% | -$25K |
|
995
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.76B
| $87.3K | ﹤0.01% |
+2,644
| New | +$82.2K |
|
996
CNX Resources
CNX
$5.2B
| $87.1K | ﹤0.01% |
+2,585
| New | +$81.4K |
|
997
Vanguard Financials ETF
VFH
$13.7B
| $86.9K | ﹤0.01% |
683
+490
| +254% | +$58.4K |
|
998
Twilio
TWLO
$29.3B
| $86.8K | ﹤0.01% |
698
+261
| +60% | +$27.8K |
|
999
First Trust Growth Strength ETF
FTGS
$1.33B
| $86.8K | ﹤0.01% |
2,538
-3,716
| -59% | -$117K |
|
1000
Fox Class A
FOXA
$25.9B
| $86.6K | ﹤0.01% |
1,546
+519
| +51% | +$27.4K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Arax Advisory Partners held 3,224 positions worth $2.18B, up 40% from $1.56B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Arax Advisory Partners deployed $399M of net new capital in Q2 2025, opening 565 new positions and adding to 1,310 existing holdings. Its largest new stake was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $21.9M trimmed.
- Arax Advisory Partners's largest Q2 2025 buy was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.
- Arax Advisory Partners added most to Axon Enterprise in Q2 2025, an estimated $52.4M increase.
- Arax Advisory Partners's biggest Q2 2025 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $21.9M.
- Arax Advisory Partners fully exited YieldMax MSTR Option Income Strategy ETF in Q2 2025, selling an estimated $102K.
- Arax Advisory Partners's ten largest holdings make up 23% of its $2.18B portfolio in Q2 2025.
- Arax Advisory Partners opened 565 new positions and closed 193 in Q2 2025.
- Arax Advisory Partners's portfolio value rose 40% quarter-over-quarter to $2.18B.
Based on Arax Advisory Partners's 13F filing for Q2 2025, filed 12 Aug 2025.